Literature DB >> 11390502

Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils.

P K Epling-Burnette1, B Zhong, F Bai, K Jiang, R D Bailey, R Garcia, R Jove, J Y Djeu, T P Loughran, S Wei.   

Abstract

Polymorphonuclear neutrophils (PMN) are phagocytic cells constitutively programmed for apoptotic cell death. Exposure to GM-CSF delays apoptosis as measured by annexin-V staining and cell morphological change. We found that STAT5B, STAT1, and STAT3 DNA-binding activity was induced by GM-CSF. We also detected activation of the phosphatidylinositol 3-kinase (PI 3-kinase) pathway after GM-CSF treatment which was inhibited by treatment with the PI 3-kinase inhibitors, wortmannin and LY294002. We investigated whether STAT or PI 3-kinase activity was necessary for the pro-survival response of GM-CSF in PMN. Exposure of PMN to GM-CSF in the presence of either AG-490, antisense STAT3 oligonucleotides, or wortmannin resulted in a partial inhibition of GM-CSF-mediated pro-survival activity. GM-CSF induced a time-dependent increase in the mRNA and protein expression of the anti-apoptotic Bcl-2-family protein, Mcl-1. We examined the hypothesis that Janus kinase/STAT and PI 3-kinase regulation of Mcl-1 contributed to GM-CSF-delayed apoptosis. Using either AG-490 or wortmannin alone, we observed a dose-dependent inhibition of GM-CSF-induced Mcl-1 expression. Using suboptimal doses of AG-490 and wortmannin, we found that both drugs together had an additive effect on delayed apoptosis and Mcl-1 expression. These data suggest that cooperative regulation of Mcl-1 by the Janus kinase/STAT and PI 3-kinase pathways contribute to GM-CSF-delayed apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390502     DOI: 10.4049/jimmunol.166.12.7486

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  Stat proteins and oncogenesis.

Authors:  Jacqueline Bromberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3.

Authors:  Hong Yue; Kuniyoshi Tanaka; Tatsuhiko Furukawa; Sadashiva S Karnik; Wei Li
Journal:  Biochim Biophys Acta       Date:  2012-06-02

Review 3.  Peculiarities of cell death mechanisms in neutrophils.

Authors:  B Geering; H-U Simon
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

4.  Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors.

Authors:  George Z Rassidakis; Raymond Lai; Timothy J McDonnell; Fernando Cabanillas; Andreas H Sarris; L Jeffrey Medeiros
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 5.  Regulation of neutrophil functions by proinflammatory cytokines.

Authors:  Takayuki Kato; Seiichi Kitagawa
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 6.  Mcl-1 is vital for neutrophil survival.

Authors:  Mark P Murphy; Emma Caraher
Journal:  Immunol Res       Date:  2015-06       Impact factor: 2.829

Review 7.  Chemical modulation of transcription factors.

Authors:  Bianca Wiedemann; Jörn Weisner; Daniel Rauh
Journal:  Medchemcomm       Date:  2018-07-11       Impact factor: 3.597

8.  Involvement of protein kinase D in Fc gamma-receptor activation of the NADPH oxidase in neutrophils.

Authors:  Jan K Davidson-Moncada; Guillermo Lopez-Lluch; Anthony W Segal; Lodewijk V Dekker
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

Review 9.  Mechanisms regulating neutrophil survival and cell death.

Authors:  María Laura Gabelloni; Analía Silvina Trevani; Juan Sabatté; Jorge Geffner
Journal:  Semin Immunopathol       Date:  2013-02-01       Impact factor: 9.623

10.  A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells.

Authors:  Michel Jourdan; Jean-Luc Veyrune; John De Vos; Nicole Redal; Guilhem Couderc; Bernard Klein
Journal:  Oncogene       Date:  2003-05-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.